Search Results

1 - 10 of 10 items :

  • Clinical Medicine x
  • Anatomy and Physiology x
Clear All
Romanian Journal of Diabetes Nutrition and Metabolic Diseases
The Journal of Romanian Society of Diabetes Nutrition and Metabolic Diseases
Open access
Assessment of Nutritional Status in Patients with Metabolic Syndrome and Chronic Hepatitis C

References 1. Ismail FW, Khan RA, Kamani L et al. Nutritional status in patients with hepatitis C. J Coll Physicians Surg Pak 22: 139-142, 2012. 2. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 14: 1-21, 2010. 3. Gheorghe L, Grigorescu M, Iacob S et al. Effectiveness and tolerability of pegylated Interferon alpha-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice. Rom J Gastroenterol 14

Open access
Body Mass Index and Glycaemic Control in Patients with Diabetes Mellitus: A Case-Control Study

. Public Health Nutr 14: 119-126, 2011. 7. Knowler WC, Fowler SE, Hamman RF et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374(9702): 1677-1686, 2009. 8. El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS. Association of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetes. Arch Intern Med 163: 69- 75, 2003. 9. Garber AJ. Obesity and type 2 diabetes: which patients are at risk? Diabetes

Open access
Optimization of Efficacy of Core Strengthening Exercise Protocols on Patients Suffering from Diabetes Mellitus

R eferences 1. International Diabetes federation . DMAtlas . 7, 2015. Accessed at: http://www.idf.org/sites/default/files/Atlas7e-poster.pdf . 2. Kaur J, Singh SK, Vij JS. Physiotherapy and Rehabilitation in the management of DM: A Review. Indian J Sci Res 6(2): 171-181, 2015. 3. Fulk GD, Robinson CJ, Mondal S, Storey CM, Hollister AM. The effects of diabetes and/or peripheral neuropathy in detecting short Postural perturbations in mature adults. J Neuroeng Rehabil 7: 1-10, 2010. 4. Schwartz AV, Hillier RA, Sellmeyer DE et al

Open access
Prevalence of Dyslipidemia and Its Association with Glycemic Control in Indian Type 2 Diabetes Population

perspective. Diabetologia 38: 1061-1068, 1995. 9. Nguyen Q, Srinivasan S, Xu J, Chen W, Berenson G. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care 31: 2044-2049, 2008. 10. Eid M, Mafauzy M, Faridah AR. Dyslipidaemic pattern of patients with type 2 diabetes mellitus. Malays J Med Sci 11: 44–51, 2004. 11. Chattanda S, Mgonda Y. Diabetic dyslipidemia among diabetic patients attending specialized clinics in Dar es Salaam. Tanzania Medical Journal

Open access
Overweight and Obesity in Relation to Cardiovascular Risk Factors Among University Students in Malaysia

Nutr 10: 5-11, 2014. 7. Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci (Lond) , 125: 311-318, 2013. 8. Medical College of Georgia. Cause of gender differences in blood pressure, kidney damage under study. [online]. Retrieved March 29, 2017, from https://www.sciencedaily.com/releases/2007/05/070502111521.htm , 2007. 9. Akter SFU, Fauzi ARM, Nordin MS, et al. Prevalence of cardiovascular risk factors in a selected community at Kuantan, Pahang, Malaysia. International Journal of Medicine and Medical

Open access
Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer

References 1. Ferlay J, Soerjomataram I, Ervik M at al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 05.11.2014 2. Hart AR, Wicks AC, Mayberry JF. Colorectal cancer screening in asymptomatic populations. Gut 36: 590-598, 1995. 3. Røseth AG, Kristinsson J, Fagerhol MK at al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer

Open access
Advanced Glycation End Products Measured by Age Reader in a Group of Patients with Obesity

glycemic variability, Diabetes Technol Ther 12(7):581-5, Jul 2010. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 29: 2654-9; PMID: 17130200; DOI: 10.2337/dc05-2173, 2006.

Open access
The Evolution of Mortality and Death Causes in Type 2 Diabetes Patients from Timisoara Diabetes Centre Between 1970 And 1999

Florida Medicine Spring 2005; available at http://www.dcmsonline.org/jaxmedicine/2005journals/Diabetes/diab05g-stroke.pdf 10. Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 25: 1977-1984, 1994. 11. Laing SP, Swerdlow AJ, Carpenter LM et al . Mortality from cerebrovascular disease in a cohort of 23000 patients with insulin-treated diabetes. Stroke 34: 418-421, 2003. 12. Evans JM, Barnett KN, Ogston SA, Morris AD. Increasing prevalence of type 2

Open access
Pharmacotherapy in the Treatment of Obesity

References 1. Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384: 766-81, 2014. 2. WHO. Obesity and overweight. WHO fact sheet N°311. World Health Organization website. Geneva, Switzerland: World Health Organization; 2016 [http://www.who.int/mediacentre/factsheets/fs311/en. Accessed September 10, 2016]. 3. de Onis M, Blossner M, Borghi E

Open access